Security key
89422G107
Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)
CUSIP: 89422G107
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 92,930,114
- Total 13F shares
- 100,727,863
- Share change
- -180,642
- Total reported value
- $2,407,390,168
- Put/Call ratio
- 40%
- Reported price per share
- $23.90
- Number of holders
- 235
- Value change
- +$19,761,610
- Number of buys
- 125
- Number of sells
- 105
Security identity
Holder snapshot
Report period
Q3 2025
Institutions
235
Top holders
10
TVTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Travere Therapeutics, Inc. SEC filings
Travere Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89422G107
Recent filing periods:
Ownership snapshot
Top shareholders of TVTX - Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
JANUS HENDERSON GROUP PLC
13D/G signal
JANUS HENDERSON GROUP PLC
Evidence rows
50
Latest as of
30 Sep 2025
13D/G
13F
Lead comparable stake: 12%
13D/G row: JANUS HENDERSON GROUP PLC
Showing first 8 of 50 holder rows.
Open remaining rows
Rank 1 holder
JANUS HENDERSON GROUP PLC
13D/G
13F
- Ownership
- 12%
- Position
- $253.33M
Rank 2 holder
ARMISTICE CAPITAL, LLC
13F
13D/G
- Ownership
- 10%
- Position
- $133.19M
Rank 3 holder
BlackRock, Inc.
13D/G
13F
- Ownership
- 7.5%
- Position
- $122.62M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13D/G
13F
Company
|
12%
|
$253,331,874
10,599,660 shares
|
-$17,690,876 | 30 Sep 2025 |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
Company
|
10%
from 13D/G
|
$133,187,551
11,025,471 shares
mixed-class rows
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13D/G
13F
Company
|
7.5%
|
$122,617,344
6,689,435 shares
|
-$24,357,949 | 31 Mar 2025 |
| Rock Springs Capital Management LP |
13D/G
13F
Company
|
3.3%
|
$53,545,523
2,921,196 shares
|
-$37,621,463 | 31 Mar 2025 |
| Woodline Partners LP |
13D/G
13F
Company
|
2.4%
|
$38,750,646
2,114,056 shares
|
$0 | 31 Dec 2024 |
| MACQUARIE GROUP LTD |
13F
Company
|
5.5%
|
$75,443,000
5,097,482 shares
|
— | 30 Jun 2025 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
3%
|
$41,203,200
2,784,000 shares
|
— | 30 Jun 2025 |
| EMERALD ADVISERS, LLC |
13F
Company
|
2.3%
|
$30,952,128
2,091,360 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
235
Shares
100,727,863
Rows loaded
237
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
207
Q3 2025 holders
235
Holder diff
28
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend